[The interest and prospects of Daflon treatment in obstetrical and gynaecological practice].
Muller
P
P
Clinique Gynécologique et Obstétricale II, Hospices Civils, B. P. 426 R 5, 67005 Strasbourg, France.
Wolff
F
F
Schick
R A
RA
Szwarcberg
R
R
D002317:Cardiovascular Agents / Q000627:therapeutic use*; D004145:Diosmin / Q000627:therapeutic use*; D005260:Female; D006484:Hemorrhoids / Q000188:drug therapy; D006801:Humans; D007434:Intrauterine Devices / Q000009:adverse effects; D008595:Menorrhagia / Q000188:drug therapy; D008599:Menstruation Disturbances / Q000188:drug therapy*; D008796:Metrorrhagia / Q000188:drug therapy; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D014592:Uterine Hemorrhage / Q000517:prevention & control; D014648:Varicose Veins / Q000188:drug therapy; D014689:Venous Insufficiency / Q000188:drug therapy
D002317:Cardiovascular Agents; D004145:Diosmin